人工电子耳市场:开发平台报告(开发阶段，市场区隔，地区·国家，法规途径，主要企业)，2023年最新版

本报告提供人工电子耳市场相关调查，提供产品概要与正在开发的开发中产品趋势，参与企业的最近趋势等资讯。

目录

第1章 目录

第2章 简介

• 人工电子耳概要

第3章 开发中的产品

• 人工电子耳- 各开发阶段的开发中产品
• 人工电子耳- 各市场区隔的开发中产品
• 人工电子耳- 各地区的开发中产品
• 人工电子耳- 各法规途径的开发中产品
• 人工电子耳- 各估计核准日的开发中产品
• 人工电子耳- 进行中的临床试验

第4章 人工电子耳- 企业正在开发的开发中产品

• 人工电子耳企业- 各开发阶段的开发中产品
• 人工电子耳- 各开发阶段的开发中产品

第5章 人工电子耳的企业和产品概要

• Advanced Bionics AG
• Advanced Bionics LLC
• Auritec Pharmaceuticals Inc
• Ceragenix Pharmaceuticals, Inc.
• Cochlear Ltd
• Demant A/S
• Hannover Medical School
• Huntington Medical Research Institutes
• Labyrinth Devices
• MED-EL Elektromedizinische Gerate Gesellschaft mbH
• Naval Information Warfare Center Pacific
• Northwestern University
• OtoKinetics Inc
• Sonova Holding AG
• Tel Aviv Sourasky Medical Center
• Trinity College Dublin
• University of Michigan Pediatric Device Consortium
• University of Utah
• University of Wisconsin Madison

第6章 人工电子耳- 最近的开发

第7章 附录

Abstract

GlobalData's Medical Devices sector report, "Cochlear Implants Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update" provides comprehensive information about the Cochlear Implants pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

A Cochlear Implant (CI) Bionic ear is a device that can be surgically implanted into a person's cochlea to stimulate it to enhance or restore hearing.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

• Extensive coverage of the Cochlear Implants under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of Cochlear Implants and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
• Identify and understand important and diverse types of Cochlear Implants under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

• 1.1 List of Tables
• 1.2 List of Figures

2 Introduction

• 2.1 Cochlear Implants Overview

3 Products under Development

• 3.1 Cochlear Implants - Pipeline Products by Stage of Development
• 3.2 Cochlear Implants - Pipeline Products by Territory
• 3.3 Cochlear Implants - Pipeline Products by Regulatory Path
• 3.4 Cochlear Implants - Pipeline Products by Estimated Approval Date
• 3.5 Cochlear Implants - Ongoing Clinical Trials

4 Cochlear Implants - Pipeline Products under Development by Companies

• 4.1 Cochlear Implants Companies - Pipeline Products by Stage of Development
• 4.2 Cochlear Implants - Pipeline Products by Stage of Development

5 Cochlear Implants Companies and Product Overview

• 5.1 Advanced Bionics AG Company Overview
  • 5.1.1 Advanced Bionics AG Pipeline Products & Ongoing Clinical Trials Overview
• 5.2 Advanced Bionics LLC Company Overview
  • 5.2.1 Advanced Bionics LLC Pipeline Products & Ongoing Clinical Trials Overview
• 5.3 Auritec Pharmaceuticals Inc Company Overview
  • 5.3.1 Auritec Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.4 Ceragenix Pharmaceuticals, Inc. (Inactive) Company Overview
  • 5.4.1 Ceragenix Pharmaceuticals, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
• 5.5 Cochlear Ltd Company Overview
  • 5.5.1 Cochlear Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.6 Demant A/S Company Overview
  • 5.6.1 Demant A/S Pipeline Products & Ongoing Clinical Trials Overview
• 5.7 Hannover Medical School Company Overview
  • 5.7.1 Hannover Medical School Pipeline Products & Ongoing Clinical Trials Overview
• 5.8 Huntington Medical Research Institutes Company Overview
  • 5.8.1 Huntington Medical Research Institutes Pipeline Products & Ongoing Clinical Trials Overview
• 5.9 Labyrinth Devices Company Overview
  • 5.9.1 Labyrinth Devices Pipeline Products & Ongoing Clinical Trials Overview
• 5.10 MED-EL Elektromedizinische Gerate Gesellschaft mbH Company Overview
  • 5.10.1 MED-EL Elektromedizinische Gerate Gesellschaft mbH Pipeline Products & Ongoing Clinical Trials Overview
• 5.11 Naval Information Warfare Center Pacific Company Overview
  • 5.11.1 Naval Information Warfare Center Pacific Pipeline Products & Ongoing Clinical Trials Overview
• 5.12 Northwestern University Company Overview
  • 5.12.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
• 5.13 OtoKinetics Inc Company Overview
  • 5.13.1 OtoKinetics Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.14 Sonova Holding AG Company Overview
  • 5.14.1 Sonova Holding AG Pipeline Products & Ongoing Clinical Trials Overview
• 5.15 Tel Aviv Sourasky Medical Center Company Overview
  • 5.15.1 Tel Aviv Sourasky Medical Center Pipeline Products & Ongoing Clinical Trials Overview
• 5.16 Trinity College Dublin Company Overview
  • 5.16.1 Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview
• 5.17 University of Michigan Pediatric Device Consortium Company Overview
  • 5.17.1 University of Michigan Pediatric Device Consortium Pipeline Products & Ongoing Clinical Trials Overview
• 5.18 University of Utah Company Overview
  • 5.18.1 University of Utah Pipeline Products & Ongoing Clinical Trials Overview
• 5.19 University of Wisconsin Madison Company Overview
  • 5.19.1 University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview

6 Cochlear Implants- Recent Developments

• 6.1 Mar 02, 2023: Katya Kruglova to join Sonova's Management Board as GVP Human Resources & Communications
• 6.2 Dec 20, 2022: Advanced Bionics to pay over $12 million for alleged false claims for cochlear implant processors
• 6.3 Dec 20, 2022: Advanced Bionics to pay over $12 million for alleged false claims for cochlear implant processors
• 6.4 Dec 06, 2022: Use of hearing aids and cochlear implants associated with a decreased risk of developing dementia
• 6.5 Nov 14, 2022: Sonova Holding First half results 2022/23
• 6.6 Oct 11, 2022: SONOVA HOLDING AG Announces Investor & Analyst Day 2022
• 6.7 Oct 11, 2022: Sonova Investor & Analyst Day 2022 Leading innovation and further expanding our reach

7 Appendix

• 7.1 Methodology
• 7.2 About GlobalData
• 7.3 Contact Us
• 7.4 Disclaimer

List of Tables

List of Tables

• Cochlear Implants - Pipeline Products by Stage of Development
• Cochlear Implants - Pipeline Products by Territory
• Cochlear Implants - Pipeline Products by Regulatory Path
• Cochlear Implants - Pipeline Products by Estimated Approval Date
• Cochlear Implants - Ongoing Clinical Trials
• Cochlear Implants Companies - Pipeline Products by Stage of Development
• Cochlear Implants - Pipeline Products by Stage of Development
• Glossary

List of Figures

List of Figures

• Cochlear Implants - Pipeline Products by Stage of Development
• Cochlear Implants - Pipeline Products by Territory
• Cochlear Implants - Pipeline Products by Regulatory Path
• Cochlear Implants - Pipeline Products by Estimated Approval Date
• Cochlear Implants - Ongoing Clinical Trials